최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기韓國環境保健學會誌 = Journal of environmental health sciences, v.47 no.6, 2021년, pp.513 - 520
김지원 (존스 홉킨스 대학교 인류학과) , 조경이 (서울대학교 보건대학원 환경보건학과) , 김하나 (서울대학교 보건대학원 보건학과) , 박동욱 (한국방송통신대학교 보건환경학과)
Background: Benzalkonium chloride (BKC) has been extensively used as a preservative in industrial products and in hygiene, medical, and cosmetic applications. Humidifier disinfectant (HD) products containing BKC have been used in South Korea. Objectives: This study was aimed to review types of produ...
Korea Environmental Industry & Technology Institute (KEITI). Comprehensive Supporting Portal for Humidifier Disinfectant Victims: Statistical Data. Available: https://www.healthrelief.or.kr/home/content/stats01/view.do [accessed 30 November 2021].
Park DU, Ryu SH, Roh HS, Lee E, Cho HJ, Yoon J, et al. Association of high-level humidifier disinfectant exposure with lung injury in preschool children. Sci Total Environ. 2018; 616-617: 855-862.
Purohit A, Kopferschmitt-Kubler MC, Moreau C, Popin E, Blaumeiser M, Pauli G. Quaternary ammonium compounds and occupational asthma. Int Arch Occup Environ Health. 2000; 73(6): 423-427.
United States. Environmental Protection Agency. Reregistration Eligibility Decision for Alkyl Dimethyl Benzyl Ammonium Chloride (ADBAC). Washington, D.C.: U.S. Environmental Protection Agency; 2006.
Choi SM, Roh TH, Lim DS, Kacew S, Kim HS, Lee BM. Risk assessment of benzalkonium chloride in cosmetic products. J Toxicol Environ Health B Crit Rev. 2018; 21(1): 8-23.
European Union. Biocidal Products Regulation. Brussels: European Parliament, Council of the European Union; 2012.
European Commission. Commission Implementing Decision (EU) 2016/1950 of 4 November 2016 on the Non-Approval of Certain Biocidal Active Substances Pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council. Available: https://eur-lex.europa.eu/legal-content/en/ALL/?uriCELEX:32016D1950 [accessed 30 September 2021].
European Union (EU). Regulation (EU) 528/2012- Annex V: List of Preservatives Allowed in Cosmetic Products. Available: https://ec.europa.eu/growth/tools-databases/cosing/pdf/COSING_Annex%20V_v2.pdf [accessed 30 September 2021].
European Commission. Regulation (EC) No. 1223/2009 on Cosmetic Products - Annex III. Available: https://ec.europa.eu/health/sites/default/files/endocrine_disruptors/docs/cosmetic_1223_2009_regulation_en.pdf [accessed 30 September 2021].
Cosmetic Ingredient Review Expert Panel. Annual review of cosmetic ingredient safety assessments: 2005/2006. Int J Toxicol. 2008; 27(Suppl 1): 77-142.
US Food and Drug Administration, HHS. Safety and effectiveness of health care antiseptics; topical antimicrobial drug products for over-the-counter human use. Final rule. Fed Regist. 2017; 82(242): 60474-60503.
Japan Ministry of Health and Welfare. Standards for Cosmetics, Notification No.331. Tokyo: Ministry of Health and Welfare, Japan; 2000.
Korea Ministry of Food and Drug Safety. Regulations on Safety Standards for Cosmetics. No. 2020-12 (Amended on Feb 25, 2020). Available: https://www.mfds.go.kr/brd/m_211/view.do?seq14453 [accessed 30 September 2021].
Korea Ministry of Food and Drug Safety. Korean Manufacturing Standard for Medicine. No.2021-68 (Partly Amended and Enforced on August 9, 2021). Available: https://www.law.go.kr/%ED%96%89%EC%A0%95%EA%B7%9C%EC%B9%99/%EC%9D%98%EC%95%BD%EC%99%B8%ED%92%88%ED%91%9C%EC%A4%80%EC%A0%9C%EC%A1%B0%EA%B8%B0%EC%A4%80/(2021-68,20210809) [accessed 30 September 2021].
Korea Ministry of Food and Drug Safety. Prior Notice 1: Modification Order for Approving Drugs Containing Benzalkonium Chlorides. Available: https://nedrug.mfds.go.kr/CCBAR01F012/getList/getItem?infoNo20210099&infoClassCode3 [accessed 30 September 2021].
Korea Ministry of Food and Drug Safety. Prior Notice 2: Modification Order for Approving Drugs Containing Benzalkonium Chlorides. Available: https://nedrug.mfds.go.kr/CCBAR01F012/getList/ getItem?infoNo20210133&infoClassCode3 [accessed 30 September 2021].
Korea Ministry of Environment. Standard for Consumer Chemical Products Designated as Products Subject to Safety Confirmation and their Safety and Labeling No.2021-150 (Partly Amended and Enforced on July 30, 2021). Available: https://www.law.go.kr/admRulSc.do?menuId5&query%EC%95%88%EC%A0%84%ED%99%95%EC%9D%B8%EB%8C%80%EC%83%81%EC%83%9D%ED%99%9C%ED%99%94%ED%95%99%EC%A0%9C%ED%92%88%20%EC%A7%80%EC%A0%95%20%EB%B0%8F%20%EC%95%88%EC%A0%84%C2%B7%ED%91%9C%EC%8B%9C%EA%B8%B0%EC%A4%80#AJAX [accessed 30 September 2021].
Lewis RJ, Sax NI. Sax's Dangerous Properties of Industrial Materials, 12th ed. Oxford: Wiley-Blackwell; 2012.
Willis CM, Stephens JM, Wilkinson JD. Experimentally-induced irritant contact dermatitis. Determination of optimum irritant concentrations. Contact Dermatitis. 1988; 18(1): 20-24.
Dao H Jr, Fricker C, Nedorost ST. Sensitization prevalence for benzalkonium chloride and benzethonium chloride. Dermatitis. 2012; 23(4): 162-166.
Fisher AA. Allergic contact dermatitis and conjunctivitis from benzalkonium chloride. Cutis. 1987; 39(5): 381-383.
Suneja T, Belsito DV. Occupational dermatoses in health care workers evaluated for suspected allergic contact dermatitis. Contact Dermatitis. 2008; 58(5): 285-290.
Stanford D, Georgouras K. Allergic contact dermatitis from benzalkonium chloride in plaster of Paris. Contact Dermatitis. 1996; 35(6): 371-372.
Isaac J, Scheinman PL. Benzalkonium chloride: an irritant and sensitizer. Dermatitis. 2017; 28(6): 346-352.
Oiso N, Fukai K, Ishii M. Irritant contact dermatitis from benzalkonium chloride in shampoo. Contact Dermatitis. 2005; 52(1): 54.
Tartari F, Vincenzi C, Di Altobrando A, Bruni F, Neri I. Allergic contact dermatitis to benzalkonium chloride with erythema multiforme-like reaction in a child. Contact Dermatitis. 2020; 82(6): 397-399.
Ling T, Highet A. Irritant reactions to an antiseptic bath emollient. J Dermatol Treat. 2000; 11(4): 263-267.
Krogsrud NE, Larsen AI. Airborne irritant contact dermatitis from benzalkonium chloride. Contact Dermatitis. 1997; 36(2): 112.
Mauleon C, Mauleon P, Chavarria E, de la Cueva P, Suarez R, Lazaro P. Airborne contact dermatitis from n-alkyl dimethylbenzylammonium chloride and n-alkyl dimethylethyl-benzylammonium chloride in a detergent. Contact Dermatitis. 2006; 55(5): 311-312.
Freeman PD, Kahook MY. Preservatives in topical ophthalmic medications: historical and clinical perspectives. Expert Rev Ophthalmol. 2009; 4(1): 59-64.
Lee J. Glaucoma and ocular surface disease. J Korean Glaucoma Soc. 2019; 8(1): 33-35.
Rasmussen CA, Kaufman PL, Kiland JA. Benzalkonium chloride and glaucoma. J Ocul Pharmacol Ther. 2014; 30(2-3): 163-169.
Yu I. Medical treatment of glaucoma and ocular surface disease: from old to new. J Korean Glaucoma Soc. 2017; 6(1): 30-33.
Orsini D, D'Arino A, Pigliacelli F, Assorgi C, Latini A, Cristaudo A. Allergic contact dermatitis to dorzolamide and benzalkonium chloride. Postepy Dermatol Alergol. 2018; 35(5): 538-539.
Lee SJ, Kim M. Allergic contact dermatitis caused by dorzolamide eyedrops. Clin Ophthalmol. 2015; 9: 575-577.
Datta S, Baudouin C, Brignole-Baudouin F, Denoyer A, Cortopassi GA. The eye drop preservative benzalkonium chloride potently induces mitochondrial dysfunction and preferentially affects LHON mutant cells. Invest Ophthalmol Vis Sci. 2017; 58(4): 2406-2412.
Suzuki K, Teranishi S, Sagara T, Yoshino H, Nakayama M, Enoki M, et al. Safety and efficacy of benzalkonium chloride-optimized tafluprost in Japanese glaucoma patients with existing superficial punctate keratitis. J Glaucoma. 2015; 24(6): e145-e150.
Sezgin Akcay BI, Guney E, Bozkurt TK, Topal CS, Akkan JC, unlu C. Effects of polyquaternium- and benzalkonium-chloride-preserved travoprost on ocular surfaces: an impression cytology study. J Ocul Pharmacol Ther. 2014; 30(7): 548-553.
Cha SH, Lee JS, Oum BS, Kim CD. Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro. Clin Exp Ophthalmol. 2004; 32(2): 180-184.
George M, Joshi SV, Concepcion E, Lee H. Paradoxical bronchospasm from benzalkonium chloride (BAC) preservative in albuterol nebulizer solution in a patient with acute severe asthma. A case report and literature review of airway effects of BAC. Respir Med Case Rep. 2017; 21: 39-41.
Lee BH, Kim SH. Benzalkonium chloride induced bronchoconstriction in patients with stable bronchial asthma. Korean J Intern Med. 2007; 22(4): 244-248.
Graf P, Enerdal J, Hallen H. Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis. Arch Otolaryngol Head Neck Surg. 1999; 125(10): 1128-1132.
Lechien JR, Costa de Araujo P, De Marrez LG, Halloy JL, Khalife M, Saussez S. Contact allergy to benzalkonium chloride in patients using a steroid nasal spray: a report of 3 cases. Ear Nose Throat J. 2018; 97(1-2): E20-E22.
Vandenplas O, D'Alpaos V, Evrard G, Jamart J, Thimpont J, Huaux F, et al. Asthma related to cleaning agents: a clinical insight. BMJ Open. 2013; 3(9): e003568.
The Mount Sinai Selikoff Centers for Occupational Health. Quaternary Ammonium Compounds in Cleaning Products: Health & Safety Information for Cleaners and Supervisors. Available: https://www.mountsinai.org/files/MSHealth/Assets/HS/Patient-Care/Service-Areas/Occupational-Medicine/QACsInfoforWorkers_18.pdf [accessed 30 September 2021].
Park DU, Kwon JH, Park JH, Oh HB. Analysis of Components of Disinfectant Contained in Humidifier Disinfectant Products. Seoul: Special Committee for Examining the Cause of Tragedy caused by Humidifier Disinfectant (SCECTHD); 2020.
KOSHA. Study on the Respiratory Toxicity of Biocide, Benzalknonium Chloride. Available: https://oshri.kosha.or.kr/oshri/publication/researchReportSearch.do?modeview&articleNo411076&article.offset130&articleLimit10 [accessed 30 September 2021].
Johnson NF. Pulmonary toxicity of benzalkonium chloride. J Aerosol Med Pulm Drug Deliv. 2018; 31(1): 1-17.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.